Nutritional Ketosis as a Potential Treatment for Alcohol Use Disorder

Alcohol use disorder (AUD) is a chronic, relapsing brain disorder, characterized by compulsive alcohol seeking and disrupted brain function. In individuals with AUD, abstinence from alcohol often precipitates withdrawal symptoms than can be life threatening. Here, we review evidence for nutritional ketosis as a potential means to reduce withdrawal and alcohol craving. We also review the underlying mechanisms of action of ketosis. Several findings suggest that during alcohol intoxication there is a shift from glucose to acetate metabolism that is enhanced in individuals with AUD. During withdrawal, there is a decline in acetate levels that can result in an energy deficit and could contribute to neurotoxicity. A ketogenic diet or ingestion of a ketone ester elevates ketone bodies (acetoacetate, β-hydroxybutyrate and acetone) in plasma and brain, resulting in nutritional ketosis. These effects have been shown to reduce alcohol withdrawal symptoms, alcohol craving, and alcohol consumption in both preclinical and clinical studies. Thus, nutritional ketosis may represent a unique treatment option for AUD: namely, a nutritional intervention that could be used alone or to augment the effects of medications.

[1]  E. Day,et al.  Clinical Management of the Alcohol Withdrawal Syndrome. , 2021, Addiction.

[2]  C. Guerri,et al.  Ketogenic Diet Decreases Alcohol Intake in Adult Male Mice , 2021, Nutrients.

[3]  C. Martins,et al.  Ketogenic diets and appetite regulation , 2021, Current opinion in clinical nutrition and metabolic care.

[4]  Dana E. Feldman,et al.  Ketogenic diet reduces alcohol withdrawal symptoms in humans and alcohol intake in rodents , 2021, Science Advances.

[5]  A. Pillai,et al.  Randomized crossover trial of a modified ketogenic diet in Alzheimer’s disease , 2021, Alzheimer's research & therapy.

[6]  H. Schmidt,et al.  Testing the effects of the GLP-1 receptor agonist exenatide on cocaine self-administration and subjective responses in humans with cocaine use disorder. , 2021, Drug and alcohol dependence.

[7]  A. Bianco,et al.  Effects of Two Months of Very Low Carbohydrate Ketogenic Diet on Body Composition, Muscle Strength, Muscle Area, and Blood Parameters in Competitive Natural Body Builders , 2021, Nutrients.

[8]  A. Gjedde,et al.  Effects of ketogenic diet and ketone monoester supplement on acute alcohol withdrawal symptoms in male mice , 2021, Psychopharmacology.

[9]  J. Guigonis,et al.  Ingested Ketone Ester Leads to a Rapid Rise of Acetyl-CoA and Competes with Glucose Metabolism in the Brain of Non-Fasted Mice , 2021, International journal of molecular sciences.

[10]  I. Spigelman,et al.  Long-Acting Glucagon-Like Peptide-1 Receptor Agonists Suppress Voluntary Alcohol Intake in Male Wistar Rats , 2020, Frontiers in Neuroscience.

[11]  P. Kwan,et al.  Seven‐tesla quantitative magnetic resonance spectroscopy of glutamate, γ‐aminobutyric acid, and glutathione in the posterior cingulate cortex/precuneus in patients with epilepsy , 2020, Epilepsia.

[12]  Yali Zhang,et al.  Beta-Hydroxybutyrate Enhances BDNF Expression by Increasing H3K4me3 and Decreasing H2AK119ub in Hippocampal Neurons , 2020, Frontiers in Neuroscience.

[13]  K. Verbeke,et al.  Gut Microbiota-Induced Changes in β-Hydroxybutyrate Metabolism Are Linked to Altered Sociability and Depression in Alcohol Use Disorder. , 2020, Cell reports.

[14]  M. Saraga,et al.  Ketogenic diet in bipolar disorder , 2020, Bipolar disorders.

[15]  N. Volkow,et al.  Elevated thalamic glutamate levels and reduced water diffusivity in alcohol use disorder: Association with impulsivity , 2020, Psychiatry Research: Neuroimaging.

[16]  W. Węglarz,et al.  MRI spectroscopic and tractography studies indicate consequences of long-term ketogenic diet , 2020, Brain Structure and Function.

[17]  Yu-Chen Huang,et al.  Gabapentinoids for treatment of alcohol use disorder: A systematic review and meta‐analysis , 2020, Human psychopharmacology.

[18]  Mark S. Schmidt,et al.  Nicotinamide Adenine Dinucleotide Metabolome Is Functionally Depressed in Patients Undergoing Liver Transplantation for Alcohol‐Related Liver Disease , 2020, Hepatology communications.

[19]  A. McQuillin,et al.  Genome-wide meta-analysis of problematic alcohol use in 435,563 individuals yields insights into biology and relationships with other traits , 2020, Nature Neuroscience.

[20]  C. Soares,et al.  Exploring the mechanisms of action of the antidepressant effect of the ketogenic diet , 2020, Reviews in the neurosciences.

[21]  E. Kang,et al.  SGLT2 inhibition modulates NLRP3 inflammasome activity via ketones and insulin in diabetes with cardiovascular disease , 2020, Nature Communications.

[22]  Samar Malaeb,et al.  A Case of Hypoglycemia Associated With the Ketogenic Diet and Alcohol Use , 2020, Journal of the Endocrine Society.

[23]  Syed Fahad Sultan,et al.  Diet modulates brain network stability, a biomarker for brain aging, in young adults , 2020, Proceedings of the National Academy of Sciences.

[24]  M. Iwata,et al.  Prefrontal cortex infusion of beta‐hydroxybutyrate, an endogenous NLRP3 inflammasome inhibitor, produces antidepressant‐like effects in a rodent model of depression , 2020, Neuropsychopharmacology reports.

[25]  Étienne Myette-Côté,et al.  The Impact of Acute Ingestion of a Ketone Monoester Drink on LPS-Stimulated NLRP3 Activation in Humans with Obesity , 2020, Nutrients.

[26]  E. Croteau,et al.  Metabolism of Exogenous D-Beta-Hydroxybutyrate, an Energy Substrate Avidly Consumed by the Heart and Kidney , 2020, Frontiers in Nutrition.

[27]  H. Berthoud,et al.  FGF21 and the Physiological Regulation of Macronutrient Preference , 2020, Endocrinology.

[28]  R. Veech,et al.  A Dietary Ketone Ester Normalizes Abnormal Behavior in a Mouse Model of Alzheimer’s Disease , 2020, International journal of molecular sciences.

[29]  Joseph P. Schacht,et al.  Intraindividual changes in brain GABA, glutamate, and glutamine during monitored abstinence from alcohol in treatment‐naive individuals with alcohol use disorder , 2020, Addiction biology.

[30]  K. Clarke,et al.  Safety and tolerability of sustained exogenous ketosis using ketone monoester drinks for 28 days in healthy adults. , 2019, Regulatory toxicology and pharmacology : RTP.

[31]  K. Kinzig,et al.  Attenuation of stress-induced weight loss with a ketogenic diet , 2019, Physiology & Behavior.

[32]  F. Reimann,et al.  Suppression of enteroendocrine cell glucagon-like peptide (GLP)-1 release by fat-induced small intestinal ketogenesis: a mechanism targeted by Roux-en-Y gastric bypass surgery but not by preoperative very-low-calorie diet , 2019, Gut.

[33]  R. Pluta,et al.  Ketogenic Diet and Epilepsy , 2019, Nutrients.

[34]  A. Włodarczyk,et al.  Mechanisms of action of the ketogenic diet in depression , 2019, Neuroscience & Biobehavioral Reviews.

[35]  A. Gyorkos,et al.  Carbohydrate-restricted Diet and Exercise Increase Brain-derived Neurotrophic Factor and Cognitive Function: A Randomized Crossover Trial , 2019, Cureus.

[36]  A. Kraeuter,et al.  Ketogenic diet for schizophrenia: clinical implication. , 2019, Current opinion in psychiatry.

[37]  N. Volkow,et al.  Association Between Reduced Brain Glucose Metabolism and Cortical Thickness in Alcoholics: Evidence of Neurotoxicity. , 2019, The international journal of neuropsychopharmacology.

[38]  A. Tagliabue,et al.  Long-Term Effects of a Classic Ketogenic Diet on Ghrelin and Leptin Concentration: A 12-Month Prospective Study in a Cohort of Italian Children and Adults with GLUT1-Deficiency Syndrome and Drug Resistant Epilepsy , 2019, Nutrients.

[39]  G. Biagini,et al.  Ghrelin Plasma Levels After 1 Year of Ketogenic Diet in Children With Refractory Epilepsy , 2019, Front. Nutr..

[40]  A. Pradhan,et al.  Effect of Histone Deacetylase Inhibitor on Ethanol Withdrawal-Induced Hyperalgesia in Rats , 2019, The international journal of neuropsychopharmacology.

[41]  E. Westman,et al.  The ketogenic diet and remission of psychotic symptoms in schizophrenia: Two case studies , 2019, Schizophrenia Research.

[42]  J. Little,et al.  Oral Ketone Supplementation Acutely Increases Markers of NLRP3 Inflammasome Activation in Human Monocytes , 2019, Molecular nutrition & food research.

[43]  R. Haralick Dependence , 2019, Pattern Recognit. Lett..

[44]  E. Jerlhag,et al.  Brain region specific glucagon-like peptide-1 receptors regulate alcohol-induced behaviors in rodents , 2019, Psychoneuroendocrinology.

[45]  K. Durkalec-Michalski,et al.  Effect of a four-week ketogenic diet on exercise metabolism in CrossFit-trained athletes , 2019, Journal of the International Society of Sports Nutrition.

[46]  P. Tsao,et al.  Genome-wide association study of alcohol consumption and use disorder in 274,424 individuals from multiple populations , 2019, Nature Communications.

[47]  S. Mihic,et al.  Ketone body modulation of ligand-gated ion channels , 2019, Neuropharmacology.

[48]  R. Seeley,et al.  Glucagon-Like Peptide-1 Receptor Agonist Treatment Does Not Reduce Abuse-Related Effects of Opioid Drugs , 2019, eNeuro.

[49]  L. Good,et al.  Brain metabolism modulates neuronal excitability in a mouse model of pyruvate dehydrogenase deficiency , 2019, Science Translational Medicine.

[50]  S. Kenig,et al.  Weight loss, improved physical performance, cognitive function, eating behavior, and metabolic profile in a 12-week ketogenic diet in obese adults. , 2019, Nutrition research.

[51]  Marcella Rietschel,et al.  Effects of leptin and ghrelin on neural cue-reactivity in alcohol addiction: Two streams merge to one river? , 2019, Psychoneuroendocrinology.

[52]  M. Ota,et al.  Effects of a medium-chain triglyceride-based ketogenic formula on cognitive function in patients with mild-to-moderate Alzheimer’s disease , 2019, Neuroscience Letters.

[53]  R. Veech,et al.  The “great” controlling nucleotide coenzymes , 2019, IUBMB life.

[54]  J. Holst,et al.  Effects of glucagon-like peptide 1 analogs on alcohol intake in alcohol-preferring vervet monkeys , 2018, Psychopharmacology.

[55]  P. López-Jaramillo,et al.  Effect of A Very Low-Calorie Ketogenic Diet on Food and Alcohol Cravings, Physical and Sexual Activity, Sleep Disturbances, and Quality of Life in Obese Patients , 2018, Nutrients.

[56]  R. Bataller,et al.  β-Hydroxybutyrate protects from alcohol-induced liver injury via a Hcar2-cAMP dependent pathway. , 2018, Journal of hepatology.

[57]  S. Masino,et al.  Ketogenic Diet Modulates NAD+-Dependent Enzymes and Reduces DNA Damage in Hippocampus , 2018, Front. Cell. Neurosci..

[58]  Xinliang Zhu,et al.  Beta-hydroxybutyrate Promotes the Expression of BDNF in Hippocampal Neurons under Adequate Glucose Supply , 2018, Neuroscience.

[59]  Matthew C L Phillips,et al.  Low‐fat versus ketogenic diet in Parkinson's disease: A pilot randomized controlled trial , 2018, Movement disorders : official journal of the Movement Disorder Society.

[60]  Kunal Sikder,et al.  High Fat Diet Upregulates Fatty Acid Oxidation and Ketogenesis via Intervention of PPAR- γ , 2018, Cellular Physiology and Biochemistry.

[61]  R. Gruetter,et al.  Nutritional Ketosis Increases NAD+/NADH Ratio in Healthy Human Brain: An in Vivo Study by 31P-MRS , 2018, Front. Nutr..

[62]  M. Rietschel,et al.  Ghrelin modulates mesolimbic reactivity to alcohol cues in alcohol‐addicted subjects: a functional imaging study , 2018, Addiction biology.

[63]  K. Whittingstall,et al.  Ketogenic Medium Chain Triglycerides Increase Brain Energy Metabolism in Alzheimer's Disease. , 2018, Journal of Alzheimer's disease : JAD.

[64]  The Oxford Handbook of Stress and Mental Health , 2018 .

[65]  S. Kliewer,et al.  The Hormone FGF21 Stimulates Water Drinking in Response to Ketogenic Diet and Alcohol. , 2018, Cell metabolism.

[66]  Sharlene D. Newman,et al.  Effects of Alcohol Cues on MRS Glutamate Levels in the Anterior Cingulate , 2018, Alcohol and alcoholism.

[67]  A. Lum-Jones,et al.  A modified ketogenic gluten-free diet with MCT improves behavior in children with autism spectrum disorder , 2018, Physiology & Behavior.

[68]  K. Clarke,et al.  Prior ingestion of exogenous ketone monoester attenuates the glycaemic response to an oral glucose tolerance test in healthy young individuals , 2018, The Journal of physiology.

[69]  M. Nakazato,et al.  The Homeostatic Force of Ghrelin. , 2018, Cell metabolism.

[70]  L. Ferrucci,et al.  Evidence for brain glucose dysregulation in Alzheimer's disease , 2018, Alzheimer's & Dementia.

[71]  Yunbing Wang,et al.  Ketogenic diet for treatment of intractable epilepsy in adults: A meta‐analysis of observational studies , 2018, Epilepsia open.

[72]  H. Schmidt,et al.  Glucagon-like peptide-1 receptor activation in the ventral tegmental area attenuates cocaine seeking in rats , 2018, Neuropsychopharmacology.

[73]  N. Volkow,et al.  Ketogenic Diet Suppresses Alcohol Withdrawal Syndrome in Rats , 2018, Alcoholism, clinical and experimental research.

[74]  E. Tai,et al.  A high carbohydrate, but not fat or protein meal attenuates postprandial ghrelin, PYY and GLP-1 responses in Chinese men , 2018, PloS one.

[75]  R. Swerdlow,et al.  Feasibility and efficacy data from a ketogenic diet intervention in Alzheimer's disease , 2017, Alzheimer's & dementia.

[76]  K. Clarke,et al.  A Ketone Ester Drink Lowers Human Ghrelin and Appetite , 2017, Obesity.

[77]  R. Seeley,et al.  Dietary Manipulations That Induce Ketosis Activate the HPA Axis in Male Rats and Mice: A Potential Role for Fibroblast Growth Factor-21 , 2018, Endocrinology.

[78]  S. Masino,et al.  Ketone-Based Metabolic Therapy: Is Increased NAD+ a Primary Mechanism? , 2017, Front. Mol. Neurosci..

[79]  A. Fink-Jensen,et al.  The glucagon-like peptide 1 receptor agonist Exendin-4 decreases relapse-like drinking in socially housed mice , 2017, Pharmacology Biochemistry and Behavior.

[80]  Nora D. Volkow,et al.  Neurochemical and metabolic effects of acute and chronic alcohol in the human brain: Studies with positron emission tomography , 2017, Neuropharmacology.

[81]  T. Horvath,et al.  Ghrelin is Supressed by Intravenous Alcohol and is Related to Stimulant and Sedative Effects of Alcohol , 2017, Alcohol and alcoholism.

[82]  E. Croteau,et al.  Inverse relationship between brain glucose and ketone metabolism in adults during short-term moderate dietary ketosis: A dual tracer quantitative positron emission tomography study , 2017, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[83]  R. Jankord,et al.  Nutritional Ketosis Affects Metabolism and Behavior in Sprague-Dawley Rats in Both Control and Chronic Stress Environments , 2017, Front. Mol. Neurosci..

[84]  J. Rehfeld,et al.  Timeline of changes in appetite during weight loss with a ketogenic diet , 2017, International Journal of Obesity.

[85]  A. Dixon,et al.  Mitochondrial ROS induced by chronic ethanol exposure promote hyper-activation of the NLRP3 inflammasome☆ , 2017, Redox biology.

[86]  M. Mattson,et al.  Effects of a dietary ketone ester on hippocampal glycolytic and tricarboxylic acid cycle intermediates and amino acids in a 3xTgAD mouse model of Alzheimer's disease , 2017, Journal of neurochemistry.

[87]  E. Kossoff,et al.  Complications During Ketogenic Diet Initiation: Prevalence, Treatment, and Influence on Seizure Outcomes. , 2017, Pediatric neurology.

[88]  Ann K. Shinn,et al.  Redox Dysregulation in Schizophrenia Revealed by in vivo NAD+/NADH Measurement , 2017, Schizophrenia bulletin.

[89]  G. Juhász,et al.  Exogenous Ketone Supplements Reduce Anxiety-Related Behavior in Sprague-Dawley and Wistar Albino Glaxo/Rijswijk Rats , 2016, Front. Mol. Neurosci..

[90]  G. Juhász,et al.  Exogenous Ketone Supplements Reduce Anxiety-Related Behavior in Sprague-Dawley and Wistar Albino Glaxo/Rijswijk Rats , 2016, Front. Mol. Neurosci..

[91]  M. Mattson,et al.  3‐Hydroxybutyrate regulates energy metabolism and induces BDNF expression in cerebral cortical neurons , 2016, Journal of neurochemistry.

[92]  P. Jolliet,et al.  Benzodiazepine dependence in subjects with alcohol use disorders: what prevalence? , 2016, Expert opinion on drug safety.

[93]  S. Neubauer,et al.  Nutritional Ketosis Alters Fuel Preference and Thereby Endurance Performance in Athletes. , 2016, Cell metabolism.

[94]  K. Reynolds,et al.  The effects of a low-carbohydrate diet on appetite: A randomized controlled trial. , 2016, Nutrition, metabolism, and cardiovascular diseases : NMCD.

[95]  Sama F. Sleiman,et al.  Exercise promotes the expression of brain derived neurotrophic factor (BDNF) through the action of the ketone body β-hydroxybutyrate , 2016, eLife.

[96]  Bhavna S. Paratala,et al.  FGF21 Regulates Sweet and Alcohol Preference. , 2016, Cell Metabolism.

[97]  R. Judd,et al.  Anti-inflammatory effects of the hydroxycarboxylic acid receptor 2. , 2016, Metabolism: clinical and experimental.

[98]  P. Maccioni,et al.  The glucagon‐like peptide 1 receptor agonist liraglutide attenuates the reinforcing properties of alcohol in rodents , 2015, Addiction biology.

[99]  E. Verdin NAD+ in aging, metabolism, and neurodegeneration , 2015, Science.

[100]  V. Karpyak,et al.  Sex and gender-related differences in alcohol use and its consequences: Contemporary knowledge and future research considerations. , 2015, Drug and alcohol dependence.

[101]  K. Hashimoto,et al.  BDNF–TrkB signaling in the nucleus accumbens shell of mice has key role in methamphetamine withdrawal symptoms , 2015, Translational Psychiatry.

[102]  I. Torres,et al.  Protracted alcohol abstinence induces analgesia in rats: Possible relationships with BDNF and interleukin-10 , 2015, Pharmacology Biochemistry and Behavior.

[103]  R. Sun,et al.  Invariant NKT cells promote alcohol-induced steatohepatitis through interleukin-1β in mice. , 2015, Journal of hepatology.

[104]  N. Dilbaz,et al.  Relationship between craving and ghrelin, adiponectin, and resistin levels in patients with alcoholism. , 2015, Alcoholism, clinical and experimental research.

[105]  Kamil Ugurbil,et al.  In vivo NAD assay reveals the intracellular NAD contents and redox state in healthy human brain and their age dependences , 2015, Proceedings of the National Academy of Sciences.

[106]  A. Gasbarrini,et al.  Identification and Management of Alcohol Withdrawal Syndrome , 2015, Drugs.

[107]  P. A. Crawford,et al.  Ketone body β-hydroxybutyrate blocks the NLRP3 inflammasome-mediated inflammatory disease , 2015, Nature Medicine.

[108]  F. Liu,et al.  The neuroprotective effects of β-hydroxybutyrate on Aβ-injected rat hippocampus in vivo and in Aβ-treated PC-12 cells in vitro , 2015, Free radical research.

[109]  F. Greenway,et al.  Pilot feasibility and safety study examining the effect of medium chain triglyceride supplementation in subjects with mild cognitive impairment: A randomized controlled trial , 2015, BBA clinical.

[110]  Xiaojia Li,et al.  Efficacy of and Patient Compliance with a Ketogenic Diet in Adults with Intractable Epilepsy: A Meta-Analysis , 2015, Journal of clinical neurology.

[111]  T. Vanitallie,et al.  A new way to produce hyperketonemia: Use of ketone ester in a case of Alzheimer's disease , 2015, Alzheimer's & Dementia.

[112]  Leah C. S. Cepko,et al.  Ghrelin alters the stimulatory effect of cocaine on ethanol intake following mesolimbic or systemic administration , 2014, Neuropharmacology.

[113]  K. Kiianmaa,et al.  Innate BDNF expression is associated with ethanol intake in alcohol-preferring AA and alcohol-avoiding ANA rats , 2014, Brain Research.

[114]  E. Jerlhag,et al.  Role of Appetite-Regulating Peptides in the Pathophysiology of Addiction: Implications for Pharmacotherapy , 2014, CNS Drugs.

[115]  D. Moller,et al.  FGF21-based pharmacotherapy – potential utility for metabolic disorders , 2014, Trends in Endocrinology & Metabolism.

[116]  M. Tamura,et al.  Acetaldehyde is an oxidative stressor for gastric epithelial cells , 2014, Journal of clinical biochemistry and nutrition.

[117]  H. Chen,et al.  The β-hydroxybutyrate receptor HCA2 activates a neuroprotective subset of macrophages , 2014, Nature Communications.

[118]  H. Kranzler,et al.  Pharmacotherapy of alcohol use disorders: seventy-five years of progress. , 2014, Journal of studies on alcohol and drugs. Supplement.

[119]  P. Mulholland,et al.  Neurochemical mechanisms of alcohol withdrawal. , 2014, Handbook of clinical neurology.

[120]  G. Núñez,et al.  Alcohol-Induced Liver Injury Is Modulated by Nlrp3 and Nlrc4 Inflammasomes in Mice , 2013, Mediators of inflammation.

[121]  R. El-Mallakh,et al.  The ketogenic diet for type II bipolar disorder , 2013, Neurocase.

[122]  G. Szabo,et al.  Alcohol‐induced IL‐1β in the brain is mediated by NLRP3/ASC inflammasome activation that amplifies neuroinflammation , 2013, Journal of leukocyte biology.

[123]  Walter Heindel,et al.  Craving in Alcohol-Dependent Patients After Detoxification Is Related to Glutamatergic Dysfunction in the Nucleus Accumbens and the Anterior Cingulate Cortex , 2013, Neuropsychopharmacology.

[124]  A. Shulkes,et al.  Ketosis and appetite-mediating nutrients and hormones after weight loss , 2013, European Journal of Clinical Nutrition.

[125]  S. Kliewer,et al.  FGF21 regulates circadian behavior and metabolism by acting on the nervous system , 2013, Nature medicine.

[126]  M. Mattson,et al.  A ketone ester diet exhibits anxiolytic and cognition-sparing properties, and lessens amyloid and tau pathologies in a mouse model of Alzheimer's disease , 2013, Neurobiology of Aging.

[127]  C. Gonçalves,et al.  Brain changes in BDNF and S100B induced by ketogenic diets in Wistar rats. , 2013, Life sciences.

[128]  Jean Martinez,et al.  Ghrelin knockout mice show decreased voluntary alcohol consumption and reduced ethanol-induced conditioned place preference , 2013, Peptides.

[129]  John H Krystal,et al.  Increased brain uptake and oxidation of acetate in heavy drinkers. , 2013, The Journal of clinical investigation.

[130]  E. Wirrell,et al.  Ketogenic Diet , 2013, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

[131]  Gary Yellen,et al.  The ketogenic diet: metabolic influences on brain excitability and epilepsy , 2013, Trends in Neurosciences.

[132]  Eric Verdin,et al.  Suppression of Oxidative Stress by β-Hydroxybutyrate, an Endogenous Histone Deacetylase Inhibitor , 2013, Science.

[133]  Nora D. Volkow,et al.  Acute alcohol intoxication decreases glucose metabolism but increases acetate uptake in the human brain , 2013, NeuroImage.

[134]  J. Kim,et al.  The effects of alcohol abstinence on BDNF, ghrelin, and leptin secretions in alcohol-dependent patients with glucose intolerance. , 2013, Alcoholism, clinical and experimental research.

[135]  R. Lecomte,et al.  The ketogenic diet increases brain glucose and ketone uptake in aged rats: A dual tracer PET and volumetric MRI study , 2012, Brain Research.

[136]  P. Llorca,et al.  Alteration of glutamate/GABA balance during acute alcohol withdrawal in emergency department: a prospective analysis. , 2012, Alcohol and alcoholism.

[137]  D. Meyerhoff,et al.  Glutamate, GABA, and other cortical metabolite concentrations during early abstinence from alcohol and their associations with neurocognitive changes. , 2012, Drug and alcohol dependence.

[138]  T. Vanitallie,et al.  Kinetics, safety and tolerability of (R)-3-hydroxybutyl (R)-3-hydroxybutyrate in healthy adult subjects. , 2012, Regulatory toxicology and pharmacology : RTP.

[139]  Patrice D Cani,et al.  The Loss of Metabolic Control on Alcohol Drinking in Heavy Drinking Alcohol-Dependent Subjects , 2012, PloS one.

[140]  A. Koopmann,et al.  The association of the appetitive peptide acetylated ghrelin with alcohol craving in early abstinent alcohol dependent individuals , 2012, Psychoneuroendocrinology.

[141]  M. Daglish,et al.  Prevalence of malnutrition and nutritional risk factors in patients undergoing alcohol and drug treatment. , 2012, Nutrition.

[142]  A. Sartorius,et al.  Translational Magnetic Resonance Spectroscopy Reveals Excessive Central Glutamate Levels During Alcohol Withdrawal in Humans and Rats , 2012, Biological Psychiatry.

[143]  P. Monteleone,et al.  Ghrelin system in alcohol‐dependent subjects: role of plasma ghrelin levels in alcohol drinking and craving , 2012, Addiction biology.

[144]  S. Bloom,et al.  Gut Hormones and Appetite Control: A Focus on PYY and GLP-1 as Therapeutic Targets in Obesity , 2012, Gut and liver.

[145]  Tatiana Foroud,et al.  ADH1B is associated with alcohol dependence and alcohol consumption in populations of European and African ancestry , 2011, Molecular Psychiatry.

[146]  A. Cederbaum Alcohol Metabolism , 2020, Encyclopedia of Gastroenterology.

[147]  A. Sakharkar,et al.  Histone deacetylases (HDAC)-induced histone modifications in the amygdala: a role in rapid tolerance to the anxiolytic effects of ethanol. , 2012, Alcoholism, clinical and experimental research.

[148]  F. Dalmay,et al.  Brain-derived neurotrophic factor serum levels in alcohol-dependent subjects 6 months after alcohol withdrawal. , 2011, Alcoholism, clinical and experimental research.

[149]  K. Behar,et al.  13C MRS studies of neuroenergetics and neurotransmitter cycling in humans , 2011, NMR in biomedicine.

[150]  E. Castrén,et al.  Alterations in BDNF and phospho-CREB levels following chronic oral nicotine treatment and its withdrawal in dopaminergic brain areas of mice , 2011, Neuroscience Letters.

[151]  R. Thoma,et al.  Perturbation of the Glutamate–Glutamine System in Alcohol Dependence and Remission , 2011, Neuropsychopharmacology.

[152]  R. Nicoll,et al.  Metabolic Control of Vesicular Glutamate Transport and Release , 2010, Neuron.

[153]  S. Kliewer,et al.  Research resource: Comprehensive expression atlas of the fibroblast growth factor system in adult mouse. , 2010, Molecular endocrinology.

[154]  M. Martínez-Chantar,et al.  Increased fibroblast growth factor 21 in obesity and nonalcoholic fatty liver disease. , 2010, Gastroenterology.

[155]  J. Flier,et al.  Fibroblast growth factor 21-deficient mice demonstrate impaired adaptation to ketosis. , 2009, Endocrinology.

[156]  P. Janak,et al.  Endogenous BDNF in the Dorsolateral Striatum Gates Alcohol Drinking , 2009, The Journal of Neuroscience.

[157]  F. Karpe,et al.  Circulating fibroblast growth factor 21 is induced by peroxisome proliferator-activated receptor agonists but not ketosis in man. , 2009, The Journal of clinical endocrinology and metabolism.

[158]  L. Costantini,et al.  Study of the ketogenic agent AC-1202 in mild to moderate Alzheimer's disease: a randomized, double-blind, placebo-controlled, multicenter trial , 2009, Nutrition & metabolism.

[159]  B. Ham,et al.  Relation between plasma brain-derived neurotrophic factor and nerve growth factor in the male patients with alcohol dependence. , 2009, Alcohol.

[160]  A. Sakharkar,et al.  Neuroscience of alcoholism: molecular and cellular mechanisms , 2009, Cellular and Molecular Life Sciences.

[161]  Yan Zeng,et al.  Effect of ethanol on hydrogen peroxide-induced AMPK phosphorylation. , 2008, American journal of physiology. Gastrointestinal and liver physiology.

[162]  J. Wheless History of the ketogenic diet , 2008, Epilepsia.

[163]  M. Eriksson,et al.  The circulating metabolic regulator FGF21 is induced by prolonged fasting and PPARalpha activation in man. , 2008, Cell metabolism.

[164]  J. Cross,et al.  The ketogenic diet for the treatment of childhood epilepsy: a randomised controlled trial , 2008, The Lancet Neurology.

[165]  P. de Timary,et al.  Alcohol dependence is associated with reduced plasma and fundic ghrelin levels , 2008, European journal of clinical investigation.

[166]  J. Pedraza-Chaverri,et al.  Antioxidant capacity contributes to protection of ketone bodies against oxidative damage induced during hypoglycemic conditions , 2008, Experimental Neurology.

[167]  Ming-Chyi Huang,et al.  Alterations of serum brain-derived neurotrophic factor levels in early alcohol withdrawal. , 2008, Alcohol and alcoholism.

[168]  R. Ugale,et al.  Brain Chromatin Remodeling: A Novel Mechanism of Alcoholism , 2008, The Journal of Neuroscience.

[169]  Margaret I Davis Ethanol-BDNF interactions: still more questions than answers. , 2008, Pharmacology & therapeutics.

[170]  Yong-Ku Kim,et al.  Decreased plasma brain-derived neurotrophic factor levels in patients with alcohol dependence. , 2007, Alcoholism, clinical and experimental research.

[171]  J. Holst The physiology of glucagon-like peptide 1. , 2007, Physiological reviews.

[172]  J. Rho,et al.  Ketone bodies are protective against oxidative stress in neocortical neurons , 2007, Journal of neurochemistry.

[173]  G. Yellen,et al.  Ketogenic Diet Metabolites Reduce Firing in Central Neurons by Opening KATP Channels , 2007, The Journal of Neuroscience.

[174]  J. Rho,et al.  Ketones inhibit mitochondrial production of reactive oxygen species production following glutamate excitotoxicity by increasing NADH oxidation , 2007, Neuroscience.

[175]  E. Nestler,et al.  Neurotrophic mechanisms in drug addiction , 2007, NeuroMolecular Medicine.

[176]  E. Capristo,et al.  Relationship between ghrelin levels, alcohol craving, and nutritional status in current alcoholic patients. , 2006, Alcoholism, clinical and experimental research.

[177]  E. Mezey,et al.  Effects of ethanol and acetaldehyde on reactive oxygen species production in rat hepatic stellate cells. , 2006, Alcoholism: Clinical and Experimental Research.

[178]  J. Kornhuber,et al.  Ghrelin levels are increased in alcoholism. , 2005, Alcoholism, clinical and experimental research.

[179]  D. Connolly,et al.  (d)-β-Hydroxybutyrate Inhibits Adipocyte Lipolysis via the Nicotinic Acid Receptor PUMA-G* , 2005, Journal of Biological Chemistry.

[180]  A. Convit,et al.  Reduced hippocampal metabolism in MCI and AD , 2005, Neurology.

[181]  D. Crabb,et al.  The role of AMP-activated protein kinase in the action of ethanol in the liver. , 2004, Gastroenterology.

[182]  C. Bondy,et al.  Caloric restriction augments brain glutamic acid decarboxylase‐65 and ‐67 expression , 2004, Journal of neuroscience research.

[183]  M. Reger,et al.  Effects of β-hydroxybutyrate on cognition in memory-impaired adults , 2004, Neurobiology of Aging.

[184]  M. Vila,et al.  D-beta-hydroxybutyrate rescues mitochondrial respiration and mitigates features of Parkinson disease. , 2003, The Journal of clinical investigation.

[185]  J. Smeitink,et al.  Application of a Ketogenic Diet in Children With Autistic Behavior: Pilot Study , 2003, Journal of child neurology.

[186]  N. Volkow,et al.  Alcohol intoxication induces greater reductions in brain metabolism in male than in female subjects. , 2003, Alcoholism, clinical and experimental research.

[187]  G. Frost,et al.  Ghrelin enhances appetite and increases food intake in humans. , 2001, The Journal of clinical endocrinology and metabolism.

[188]  K. Clarke,et al.  D-beta-hydroxybutyrate protects neurons in models of Alzheimer's and Parkinson's disease. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[189]  J. Thoen,et al.  Reduction in serum leptin and IGF-1 but preserved T-lymphocyte numbers and activation after a ketogenic diet in rheumatoid arthritis patients. , 2000, Clinical and experimental rheumatology.

[190]  J M Freeman,et al.  A multicenter study of the efficacy of the ketogenic diet. , 1998, Archives of neurology.

[191]  S. Woods,et al.  Signals that regulate food intake and energy homeostasis. , 1998, Science.

[192]  R. Saitz,et al.  Pharmacotherapies for alcohol abuse. Withdrawal and treatment. , 1997, The Medical clinics of North America.

[193]  G. Radda,et al.  Insulin, ketone bodies, and mitochondrial energy transduction , 1995, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[194]  T. Hirano,et al.  Mitochondrial glutathione depletion in alcoholic liver disease. , 1993, Alcohol.

[195]  E. Vining,et al.  Efficacy of the Ketogenic Diet for Intractable Seizure Disorders: Review of 58 Cases , 1992, Epilepsia.

[196]  R. Derr,et al.  Separation of the tremorous and muscular rigidity components of the ethanol withdrawal syndrome in the rat , 1986, Physiology & Behavior.

[197]  J. Haxby,et al.  Positron emission tomography in normal aging and Alzheimer's disease. , 1984, Psychopharmacology bulletin.

[198]  A. Cederbaum,et al.  Transfer and reoxidation of reducing equivalents as the rate-limiting steps in the oxidation of ethanol by liver cells isolated from fed and fasted rats. , 1977, Archives of biochemistry and biophysics.

[199]  P. Huttenlocher,et al.  Medium‐chain triglycerides as a therapy for intractable childhood epilepsy , 1971, Neurology.

[200]  C. Lieber,et al.  Effect of ethanol on ketone metabolism. , 1970, The Journal of clinical investigation.

[201]  G. Freund,et al.  Standardized ketosis in man following medium chain triglyceride ingestion. , 1966, Metabolism: clinical and experimental.

[202]  H. Krebs,et al.  THE METABOLISM OF GLUTAMATE IN HOMOGENATES AND SLICES OF BRAIN CORTEX. , 1963, The Biochemical journal.

[203]  P. O'hollaren Diphosphopyridine nucleotide in the prevention, diagnosis and treatment of drug addiction. A preliminary report. , 1961, Western journal of surgery, obstetrics, and gynecology.